Suzhou Lixin Pharmaceutical is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Suzhou Lixin Pharmaceutical Co., Ltd. is a privately-owned company that was established in 2000. Our company occupies 20,000 square meters of land with around 180 staffs. Currently, the company has seven production workshops for APIs and intermediates. Lixin also acquired a piece of land in Shandong Province and would going to establish a new production site for APIs and Intermediates the new factory would be on production in 2020. Suzhou Lixin Pharmaceutical was inspected and approved by US FDA in 2010 and 2015.
Company type
Manufacturer/Innovator
Products and services
Intermediates, Fine and Specialty Chemicals, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Suzhou Lixin Pharmaceutical, No.21, Tangxi Road,, Suzhou New District,, Suzhou, China, 215151
